Monocyte and Alveolar Macrophage Skewing Is Associated with the Development of Pulmonary Arterial Hypertension in a Primate Model of HIV Infection
- PMID: 30229666
- PMCID: PMC6343195
- DOI: 10.1089/AID.2018.0132
Monocyte and Alveolar Macrophage Skewing Is Associated with the Development of Pulmonary Arterial Hypertension in a Primate Model of HIV Infection
Abstract
We investigated the relationship of monocytes, alveolar, and tissue-resident macrophage populations and the development of pulmonary arterial hypertension (PAH) in a nonhuman primate model of HIV infection. A prospective study of simian immunodeficiency virus-associated pulmonary arterial hypertension (SIV-PAH) was done. Rhesus macaques (n = 21) were infected with SIV. Blood, bronchoalveolar lavage fluid (BALF), and lung tissue were analyzed for monocyte and macrophage phenotypes and inflammatory mediators. Serial right heart catheterizations were performed at three time points throughout the study to assess hemodynamic alterations and the development of PAH. All 21 animals showed similar courses of SIV infection with an increasing proinflammatory plasma environment. At 6 months postinfection (mpi), 11 of 21 animals developed SIV-PAH (mPAP ≤25 mmHg; right ventricular systolic pressure [RVSP] ≤36 mmHg). PAH+ animals had an increased frequency of proinflammatory, nonclassical monocytes (CD14dimCD16+) (p = .06) in the peripheral blood and CD14+CCR7-CD163-CD206+ macrophages (p = .04) in BALF compared with PAH- animals at 6 mpi. Increased frequencies of these monocyte and macrophage phenotypes correlated with elevated RVSP (p = .04; p = .03). In addition, PAH+ animals had greater frequencies of tissue resident inflammatory M1-like CD68+STAT1+ (p = .001) and M2a-like CD68+STAT3+ macrophages (p = .003) and a lower frequency of anti-inflammatory M2c-like CD68+STAT6+ macrophages (p = .003) as well as fewer interleukin (IL)-10+ cells (p = .01). The results suggest that HIV-PAH is associated with skewing of monocytes and alveolar macrophages toward a proinflammatory, profibrotic phenotype. Furthermore, PAH+ animals may have diminished capacity to downregulate exaggerated chronic inflammation, as indicated by lower levels of IL-10 in PAH+ animals, contributing to disease progression.
Keywords: HIV-PAH; alveolar macrophage; monocyte; nonhuman primate.
Conflict of interest statement
No competing financial interests exist.
Figures




Similar articles
-
Statin treatment prevents the development of pulmonary arterial hypertension in a nonhuman primate model of HIV-associated PAH.Sci Rep. 2019 Dec 27;9(1):19832. doi: 10.1038/s41598-019-55301-9. Sci Rep. 2019. PMID: 31882598 Free PMC article.
-
Increased monocyte turnover is associated with interstitial macrophage accumulation and pulmonary tissue damage in SIV-infected rhesus macaques.J Leukoc Biol. 2015 Jun;97(6):1147-53. doi: 10.1189/jlb.4A0914-441R. Epub 2015 Mar 16. J Leukoc Biol. 2015. PMID: 25780057 Free PMC article.
-
Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies.J Neurovirol. 2008 Aug;14(4):318-26. doi: 10.1080/13550280802132857. J Neurovirol. 2008. PMID: 18780233 Free PMC article. Review.
-
Alveolar Macrophage Dysfunction and Increased PD-1 Expression During Chronic SIV Infection of Rhesus Macaques.Front Immunol. 2019 Jul 3;10:1537. doi: 10.3389/fimmu.2019.01537. eCollection 2019. Front Immunol. 2019. PMID: 31333668 Free PMC article.
-
An SIV macaque model of SIV and HAND: the need for adjunctive therapies in HIV that target activated monocytes and macrophages.J Neurovirol. 2018 Apr;24(2):213-219. doi: 10.1007/s13365-018-0616-6. Epub 2018 Feb 12. J Neurovirol. 2018. PMID: 29435829 Review.
Cited by
-
HIV and Drug Use: A Tale of Synergy in Pulmonary Vascular Disease Development.Compr Physiol. 2023 Jun 26;13(3):4659-4683. doi: 10.1002/cphy.c210049. Compr Physiol. 2023. PMID: 37358518 Free PMC article.
-
Alveolar Macrophages in Viral Respiratory Infections: Sentinels and Saboteurs of Lung Defense.Int J Mol Sci. 2025 Jan 5;26(1):407. doi: 10.3390/ijms26010407. Int J Mol Sci. 2025. PMID: 39796262 Free PMC article. Review.
-
Exploring New Therapeutic Pathways in Pulmonary Hypertension. Metabolism, Proliferation, and Personalized Medicine.Am J Respir Cell Mol Biol. 2020 Sep;63(3):279-292. doi: 10.1165/rcmb.2020-0099TR. Am J Respir Cell Mol Biol. 2020. PMID: 32453969 Free PMC article.
-
Donepezil Ameliorates Pulmonary Arterial Hypertension by Inhibiting M2-Macrophage Activation.Front Cardiovasc Med. 2021 Mar 15;8:639541. doi: 10.3389/fcvm.2021.639541. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 33791350 Free PMC article.
-
Extracellular Vesicle TGF-β1 Is Linked to Cardiopulmonary Dysfunction in Human Immunodeficiency Virus.Am J Respir Cell Mol Biol. 2021 Oct;65(4):413-429. doi: 10.1165/rcmb.2021-0010OC. Am J Respir Cell Mol Biol. 2021. PMID: 34014809 Free PMC article.
References
-
- Rich S, Rubin LJ, Abenhail L, et al. . Executive Summary from the World Symposium on Primary Pulmonary Hypertension. Evian, France, September 6–10, 1998
-
- Sitbon O, Lascoux-Combe C, Delfraissy JF, et al. : Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med 2008;177:108–113 - PubMed
-
- Speich R, Jenni R, Opravil M, Pfab M, Russi EW: Primary pulmonary hypertension in HIV infection. Chest 1991;100:1268–1271 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous